Table 6.
Incidence rates of humeral radiolucent lines and osteolysis in the TSA/HA group at time of final follow-up, categorized per system
| Implant | No. shoulders (studies) | RLLs | Annual rate | Osteolysis | Annual rate | Follow-up (WM, yrs) |
|---|---|---|---|---|---|---|
| Affinis | 58 (3) | 10 (17.2%) | 4.0% | 9 (15.5%) | 3.6% | 4.3 |
| Eclipse | 571 (7) | 64 (11.2%) | 2.8% | 88 (15.4%) | 3.9% | 3.9 |
| Sidus | 361 (3) | 4 (1.1%) | 0.6% | 4 (1.1%) | 0.6% | 2.0 |
| Simpliciti | 196 (2) | 17 (8.7%) | 3.9% | 0 | – | 2.2 |
| TESS | 148 (4) | 0 | – | 1 (0.7%) | 0.1% | 2.9 |
| Total | 1334 (19) | 95 (7.1%) | 2.1% | 103 (7.7%) | 2% | 2.9 |
Note. TSA, total shoulder arthroplasty; HA, hemi-arthroplasty; RLLs, radiolucent lines; WM, weighted mean; yrs, years.